Skip to content

Burden of cancer in China from 1990 to 2023 and projections to 2050.

Sep 2026 · Science China Life Sciences · 0 citations · 26 references
Medicine

TL;DR

An emerging structural divergence is revealed in China's cancer burden, with incidence increasingly concentrated in women and mortality in men, and the need for sex- and age-specific cancer control strategies is highlighted.

View source

Similar papers

Sep 2026

Comprehensive analysis of colorectal cancer burden in G20 countries from 1990 to 2023 and projections to 2030: findings from the Global Burden of Disease Study 2023.

Despite substantial declines in age-standardized mortality and DALY rates, absolute CRC burden in G20 countries has increased dramatically over three decades, driven by population growth and aging.

Ke Zhang, Zhi-Fei Chen · 0 citations
Open access Sep 2026

Global burden of disease for gastric cancer from 1990 to 2023 and projections of the burden to 2035

Bayesian age-period-cohort projections indicate that by 2035, GC incidence is anticipated to reach 1,159,745, while the expected numbers of deaths and DALYs are forecasted to decline to 667,145 and 15,783,072, respectively, while the impact of GC in older age demographics is projected to increase significantly.

Liying Ma, Juan Ou, Zi-Jun Qiu et al. · 0 citations
Open access Sep 2026

The Burden of Pancreatic Cancer in ASEAN Member States (1990-2023) and Future Trends Forecasting: A GBD 2023 Analysis.

OBJECTIVE To characterize temporal trends, demographic drivers, and socioeconomic inequalities in pancreatic cancer burden across the 11 Association of Southeast Asian Nations (ASEAN) member states and to project burden through 2050. PATIENTS AND METHODS We analyzed Global Burden of Disease 2023 estimates for 11 ASEA...

Kang Fu, Yang-Dong Wu, Zhen-Yuan Liu et al. · 0 citations
Oct 2026

Trends and Projections of Esophageal Cancer Incidence and Mortality in China, 1990 to 2050: An Analysis of the Global Burden of Disease Study 2023.

Although China has markedly reduced the esophageal cancer burden since 1990, the post-2020 rebound in incidence calls for intensified surveillance and rapid evaluation of potential drivers.

Peng Su, Yan-Zhao Xu, Shi-Wang Wen et al. · 0 citations
Open access Oct 2026

Global trends in young and older adult esophageal cancer burden from 1990 to 2021

Esophageal cancer (EC) is the sixth leading cause of cancer-related mortality worldwide, and analyzing its most recent disease trends is essential for effective prevention and control strategies. Data on the global burden of EC were obtained from the 2021 Global Burden of Disease study, including prevalence, incidence,...

Yi-Fan Li, Guo-Peng Jiang, Xia Liu et al. · 0 citations
Open access Nov 2026

Global, regional and national burden of cervical cancer in 1990-2023 with forecasts to 2050: a Global Burden of Disease study.

Age-standardized incidence rate (ASIR) and age-standardized mortality rates (ASMR) were more than four and seven times higher in low- versus high-income countries, and are forecast to remain highest in low-income countries.

Natalie Pritchett, Miranda L. May, Jonathan M. Kocarnik et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.